1,761
Participants
Start Date
May 31, 2013
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
SIIL Live Attenuated Influenza Vaccine
Trivalent live-attenuated influenza vaccine 2012/2013 Northern Hemisphere vaccine containing A/California/7/2009 (H1N1), A/Victoria/361/2011 (H3N2), B/Wisconsin/1/2010
Matched placebo
Matched placebo will be identical to reconstituted SIIL LAIV in ingredients and concentrations except A/California/7/2009 (H1N1), A/Victoria/361/2011 (H3N2), B/Wisconsin/1/2010 will be replaced with egg allantoic fluid.
Institut de Recherche pour le Développement (IRD), Niakhar station, Niakhar
Institut de Recherche pour le Developpement
OTHER_GOV
Institut Pasteur de Dakar
OTHER
Centers for Disease Control and Prevention
FED
PATH
OTHER